RhumbLine Advisers’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $115K | Buy |
|
|||||
|
2024
Q1 | $4.18K | Hold |
|
|||||
|
2023
Q4 | $2.95K | Hold |
|
|||||
|
2023
Q3 | $1.39K | Hold |
|
|||||
|
2023
Q2 | $2.41K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $358K | Sell |
|
|||||
|
2021
Q4 | $481K | Buy |
|
|||||
|
2021
Q3 | $632K | Buy |
|
|||||
|
2021
Q2 | $1.01M | Sell |
|
|||||
|
2021
Q1 | $1.19M | Sell |
|
|||||
|
2020
Q4 | $968K | Buy |
|
|||||
|
2020
Q3 | $556K | Sell |
|
|||||
|
2020
Q2 | $1.33M | Buy |
|
|||||
|
2020
Q1 | $526K | Buy |
|
|||||
|
2019
Q4 | $1.2M | Sell |
|
|||||
|
2019
Q3 | $1.04M | Buy |
|
|||||
|
2019
Q2 | $1.35M | Buy |
|
|||||
|
2019
Q1 | $495K | Buy |
|
|||||
|
2018
Q4 | $541K | Buy |
|
|||||
|
2018
Q3 | $966K | Sell |
|
|||||
|
2018
Q2 | $848K | Buy |
|
|||||
|
2018
Q1 | $435K | Buy |
|